Table 1.

Summary of in vitro samples used to study the effect of the HDACI VPA on nuclear morphometry of prostate cancer cell lines

Day 3 (0 vs 0.6 mmol/L VPA)Day 3 (0 vs 1.2 mmol/L VPA)Day 7 (0 vs 0.6 mmol/L VPA)Day 7 (0 vs 1.2 mmol/L VPA)Day 14 (0 vs 0.6 mmol/L VPA)Day 14 (0 vs 1.2 mmol/L VPA)
C4-2367 (152/215)277 (152/125)413 (207/206)344 (207/137)773 (397/376)732 (397/335)
DU145365 (242/123)420 (242/178)208 (208/0)339 (208/131)808 (403/405)761 (403/358)
LNCAP417 (220/197)397 (220/177)214 (107/107)337 (107/230)746 (364/382)699 (364/335)
PC3166 (112/54)134 (112/22)203 (119/84)119 (119/0)532 (227/305)600 (227/373)

NOTE: Those in bold were not considered for analyses; 166 (112 of 54) means 112 cells in control group and 54 cells in treated group.